NCT05379348View on ClinicalTrials.gov

Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease

Active, not recruitingOBSERVATIONAL

Enrollment

1,423

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Alzheimer Disease

Interventions

OTHER

Cognitive Assessment

Montreal Cognitive Assessment - MoCA, which is a cognitive screening tool that assesses: memory, concentration, language, and orientation to time and place. this written cognitive test should take no more than 20 minutes.

Trial Locations (1)

32804

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors

collaborator

Davos Alzheimer's Collaborative

UNKNOWN

lead

AdventHealth Translational Research Institute

OTHER